U.S. Pharma Stock News

NasdaqGS:MKSI
NasdaqGS:MKSISemiconductor

Is MKS (MKSI) Resisting Special Meetings To Protect Stability Or Limit Shareholder Influence?

In late March 2026, MKS Inc. disclosed that it had received a shareholder proposal from John Chevedden seeking the right for shareholders holding a specified ownership threshold to call special shareholder meetings, and the board urged investors to vote against it at the upcoming May 11, 2026 annual meeting. This governance dispute highlights a tension between management’s preferred control over the corporate agenda and some investors’ desire for more flexible shareholder rights. Next, we...
OTCPK:SGMO
OTCPK:SGMOBiotechs

Sangamo Therapeutics (SGMO) Q4 Loss Highlights Deep TTM Deficit Challenging Bullish Profitability Hopes

Sangamo Therapeutics (SGMO) closed out FY 2025 with Q4 revenue of US$14.2 million and a basic EPS loss of US$0.11, as net income excluding extra items came in at a loss of US$37.4 million. On a trailing twelve month basis, revenue was US$39.6 million with a basic EPS loss of US$0.44 and a net loss of US$122.9 million. The company has seen quarterly revenue range from US$0.6 million to US$49.4 million across the last six reported periods, with basic EPS moving between a loss of US$0.14 and a...
NasdaqCM:DFDV
NasdaqCM:DFDVConsumer Finance

DeFi Development (DFDV) Swings To US$144.5 Million Quarterly Loss Challenging Bullish Narratives

DeFi Development (DFDV) just wrapped up FY 2025 with Q4 total revenue of US$4.5 million and a basic EPS loss of US$5.48, while trailing twelve month revenue sat at US$11.4 million against a basic EPS loss of US$4.00. Over the past six reported quarters, the company has seen quarterly revenue move from US$0.62 million in Q4 2024 to US$4.5 million in Q4 2025, with EPS swinging between a loss of US$0.05 and a profit of US$2.41 before landing back in loss-making territory. This leaves investors...
NasdaqGS:TLRY
NasdaqGS:TLRYPharmaceuticals

Tilray Brands (TLRY) Valuation Check As New Beverage Launches And Q3 Earnings Date Draw Focus

Tilray Brands (TLRY) is back in focus after fresh product launches in its beverage portfolio and the approach of its Q3 2026 earnings release and earnings call scheduled for April 1. See our latest analysis for Tilray Brands. Despite the fresh Popsicle Hard and Shock Top High Voltage launches and attention around the upcoming Q3 update, Tilray Brands’ recent share price returns point to fading momentum, with a 30 day share price return of a 17.79% decline and a 3 year total shareholder return...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI (RZLV) Revenue Surge To US$40.5 Million Tests Bearish Loss Concerns

Rezolve AI (RZLV) has just put fresh FY 2025 numbers on the table, with second half revenue of about US$40.5 million and a basic EPS loss of US$0.14, backed by trailing twelve month revenue of roughly US$46.8 million and a basic EPS loss of US$0.38. The company has seen revenue move from just US$0.1 million in the second half of FY 2024 to US$6.3 million in the first half of FY 2025 and then to US$40.5 million in the latest half, while basic EPS losses shifted from US$0.98 to US$0.25 and then...
NYSE:BKE
NYSE:BKESpecialty Retail

Is Buckle (BKE) Offering Value After Its Multi Year Share Price Surge

If you are wondering whether Buckle at around US$50.36 offers solid value or is pricing in too much optimism, this breakdown will help you frame that question clearly. The stock has had a mixed short term patch, with a 0.6% return over the last week, a 6.0% decline over the past month, and a 6.5% decline year to date, as well as a 42.9% return over the last year and 84.3% and 112.4% returns over the past 3 and 5 years. Recent coverage has focused on Buckle in the context of broader retail...
OTCPK:FKYS
OTCPK:FKYSBanks

First Keystone (OTCPK:FKYS) Quarterly Loss Challenges Bullish Narrative Around Stable Net Interest Margin

First Keystone (FKYS) just wrapped up FY 2025 with fourth quarter revenue of US$7.8 million and a basic EPS loss of US$0.10, while the trailing twelve months show total revenue of US$40.3 million and EPS of US$0.99. Over recent periods the company has seen quarterly revenue move from US$10.4 million in Q4 2024 to US$11.5 million in Q2 2025 before landing at US$7.8 million in Q4 2025, with basic EPS shifting from US$0.37 in Q4 2024 to US$0.47 in Q2 2025 before slipping into a small loss in the...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission Buyout Of Dana Unit Reshapes Growth And Valuation Profile

Allison Transmission Holdings (NYSE:ALSN) is acquiring Dana’s Off-Highway business, expanding its reach beyond on-highway applications. The deal adds exposure to off-highway markets such as construction, agriculture and mining, widening Allison’s addressable customer base. Investors now have new information to assess Allison’s mix of end markets, revenue sources and integration priorities. Allison Transmission Holdings, trading at $117.06, has seen its share price rise 18.3% year to date...
NYSE:WK
NYSE:WKSoftware

Did Workiva's (WK) New AI-Focused CFO Just Recast Its Governance and Compliance Investment Narrative?

Earlier this year, Workiva appointed Barbara Larson as executive vice president and chief financial officer, drawing on her prior finance leadership roles at Workday and VMware to help oversee its AI-enabled governance, risk, compliance and sustainability platform, which is guiding toward US$1.00 billion in revenue in 2026. Her emphasis on embedding AI more deeply into Workiva’s platform to respond to rising regulatory demands highlights how leadership decisions could shape the company’s...
NYSE:DAVA
NYSE:DAVAIT

Endava (NYSE:DAVA) Earnings Swing To Loss Challenges Bullish Profitability Narratives

Endava (NYSE:DAVA) has just turned in a mixed Q2 2026 scorecard, with revenue of £184.1 million, a basic EPS loss of £0.13 and net income loss of £6.9 million, set against a trailing twelve month picture that shows £743.9 million of revenue, a small EPS loss of £0.05 and a net income loss of £2.9 million. Over the past few quarters, revenue has moved from £195.6 million and EPS of £0.12 in Q2 2025 to £184.1 million and EPS of a £0.13 loss in Q2 2026, while quarterly net income shifted from a...
NYSE:AGX
NYSE:AGXConstruction

Broadcom And 2 More Power Grid Technology Stocks With Deep Backlogs

Global markets are wrestling with stubborn inflation risks, volatile energy prices, and shifting central bank expectations, which is pushing many investors to look more closely at real world infrastructure. The power grid sits at the heart of that topic, linking AI data centers, electrified transport, and everyday homes to reliable energy. Our Power Grid Technology Stocks screener filters for profitable companies that build and equip this backbone, focusing on those already earning money from...
NYSE:NXDT
NYSE:NXDTREITs

NexPoint Diversified Real Estate Trust (NXDT) Q4 FFO Rebound Tests Bearish Narratives

NexPoint Diversified Real Estate Trust (NXDT) has wrapped up FY 2025 with fourth quarter total revenue of US$19.1 million, basic EPS of a US$0.75 loss, and funds from operations of US$86.1 million. This rounds out a trailing 12 month revenue line of US$86.0 million and a net loss of US$130.2 million. Over recent quarters, revenue has moved from US$28.7 million in Q1 2025 to US$21.2 million in Q2, US$16.9 million in Q3, and US$19.1 million in Q4. Quarterly basic EPS has ranged from a US$0.99...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Cincinnati Financial’s 65 Year Dividend Record Meets Valuation And Earnings Test

Cincinnati Financial (NasdaqGS:CINF) has extended its dividend growth streak to 65 consecutive years. The company continues to emphasize disciplined underwriting and careful risk selection across its insurance portfolio. Management highlights investment discipline as a key support for its long running dividend track record. Cincinnati Financial focuses on property and casualty insurance, an area that regularly faces weather events and other large loss scenarios. In this context, a 65 year...
NYSE:AGBK
NYSE:AGBKBanks

Assessing AGI (AGBK) Valuation After Recent Share Price Weakness

AGI stock snapshot after recent performance shifts AGI (AGBK) has drawn attention after recent share price moves, with a 1 day gain of 1.1% contrasting with declines of 11.7% over the past week and 37.9% over the past month. See our latest analysis for AGI. The recent 1 day share price return of 1.1% sits against a weaker backdrop. The 30 day share price return of 37.9% and year to date share price return of 32.4% indicate fading momentum from earlier levels at the current share price of...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Zenas BioPharma (ZBIO): Does This $300 Million Raise Clarify or Complicate Its Funding Strategy?

In late March 2026, Zenas BioPharma completed a US$100,000,000 follow-on equity offering at US$20 per share and a US$200,000,000 issue of 2.50% senior unsecured convertible notes due April 1, 2032. This combined US$300,000,000 capital raise meaningfully reshapes the company’s funding profile, balancing immediate cash needs with future dilution through convertibles. We’ll now examine how this sizeable mix of equity and convertible debt financing influences Zenas BioPharma’s investment...
NYSE:FDS
NYSE:FDSCapital Markets

FactSet (FDS) Q2 EPS Softness Tests Bullish Margin Expansion Narrative

FactSet Research Systems (FDS) has just posted Q2 2026 results with revenue of US$611.0 million and basic EPS of US$3.60, as investors weigh these figures against ongoing earnings expectations. The company has seen quarterly revenue move from US$570.7 million in Q2 2025 to US$611.0 million in Q2 2026, while basic EPS over the same quarters shifted from US$3.81 to US$3.60, presenting a picture of higher top line with changing earnings per share. With a trailing net profit margin of 24.5% and...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter’s IV Verify Launch Tests Medication Safety Strategy And Hospital Traction

Baxter International (NYSE:BAX) has introduced the IV Verify Line Labeling System, an automated IV line labeling solution. The system is developed in an exclusive partnership with Vigilant Software to support medication safety and nurse workflow automation. The launch targets long running challenges around inconsistent IV labeling and related medication errors in clinical settings. Baxter International is putting fresh focus on clinician centric products, with IV Verify arriving as a...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

AIRO Group Holdings (AIRO) Nears Breakeven As Q4 Loss Narrows To US$0.04m

AIRO Group Holdings (AIRO) has just wrapped up FY 2025 with fourth quarter revenue of about US$48.3 million, a small net loss of roughly US$0.04 million and basic EPS close to flat at US$0.00. Trailing twelve month revenue came in at about US$90.9 million with a net loss of around US$4.1 million and basic EPS of a US$0.17 loss. Over recent periods the company has reported quarterly revenue of US$23.7 million in Q4 2024, US$11.8 million in Q1 2025, US$24.6 million in Q2, US$6.3 million in Q3...
NYSE:AON
NYSE:AONInsurance

Aon Expands AI Pay Data As Shares Trade Below Valuation Estimates

Aon (NYSE:AON) has upgraded its Radford McLagan Compensation Database to better cover artificial intelligence roles. The company has added AI specific job families, new role matching tools, and real time labor insights for employers. The changes are aimed at helping HR and compensation teams respond to growing demand for AI talent. Aon operates across risk, retirement, and health, and the Radford McLagan platform sits at the core of its human capital data offering. As AI hiring becomes a...
NasdaqCM:HQI
NasdaqCM:HQIProfessional Services

HireQuest (HQI) Margin Jump To 21.6% Tests Bullish Narratives After Softer Revenue

HireQuest (HQI) has just wrapped up FY 2025 with Q4 revenue of about US$7.0 million and basic EPS of roughly US$0.12, alongside FY 2025 trailing twelve month revenue of US$30.6 million and EPS of about US$0.47. Over the past reported quarters, revenue has moved from US$8.1 million and EPS of roughly US$0.17 in Q4 2024 to US$7.0 million and about US$0.12 in Q4 2025. During the same period, TTM revenue has ranged between US$34.6 million and US$30.6 million, and TTM EPS between roughly US$0.28...
NYSE:MNSO
NYSE:MNSOMultiline Retail

Miniso Group Holding (NYSE:MNSO) Quarterly Loss Challenges Bullish Margin Narratives

MINISO Group Holding (NYSE:MNSO) has just posted its FY 2025 results, with fourth quarter revenue of ¥6.3b and a basic EPS loss of ¥0.48, capping a trailing twelve month EPS of ¥3.92 on revenue of ¥21.4b. The company has seen quarterly revenue move from ¥4.7b and EPS of ¥2.60 in FY 2024 Q4 to ¥6.3b and EPS of negative ¥0.48 in FY 2025 Q4. Over the same period, trailing net profit margin eased from 15.2% to 10.8%, so the latest print lands in the context of solid top line scale but compressed...
NYSE:PHR
NYSE:PHRHealthcare Services

Phreesia (PHR) Turns Trailing EPS Positive And Tests Bullish Profitability Narratives

Phreesia (PHR) closed FY 2026 with Q4 revenue of US$127.1 million and basic EPS of US$0.02, capping off a trailing twelve month period where revenue reached US$480.6 million and basic EPS came in at US$0.04. Over the past six reported quarters, the company has seen quarterly revenue move from US$106.8 million in FY 2025 Q3 to US$127.1 million in FY 2026 Q4. Over the same period, basic EPS has ranged from a loss of US$0.25 per share to a profit of US$0.07 per share, pointing to a business that...
NasdaqGM:FBYD
NasdaqGM:FBYDProfessional Services

Falcon's Beyond Global (FBYD) Q3 EPS Loss Rekindles Doubts About New Profitability Narrative

Falcon's Beyond Global (FBYD) opened Q3 2025 with total revenue of US$4.1 million and a basic EPS loss of US$0.13, alongside a net income loss of US$4.9 million, setting a mixed tone around top line scale and bottom line pressure. Over recent quarters the company has seen revenue move from US$2.1 million in Q3 2024 to US$4.1 million in Q3 2025, with quarterly EPS swinging between a profit of US$0.49 in Q3 2024 and a loss of US$0.13 in the latest period as profitability remains sensitive to...
NasdaqGS:COLM
NasdaqGS:COLMLuxury

Columbia Sportswear Secures US$500m Credit Line As Shares Lag Estimates

Columbia Sportswear (NasdaqGS:COLM) entered into a new US$500 million unsecured revolving credit facility with JPMorgan Chase. The facility extends borrowing capacity for working capital and general corporate purposes through 2031. The agreement introduces new covenant conditions that may influence capital allocation and shareholder returns. Columbia Sportswear, known for outdoor apparel, footwear, and accessories, now has a sizable credit facility in place that can support its day to day...